Engaging with our industry and partners

  • News
  • Communications

FDA clearance of IND application for EP0031

22 June 2022

Exclusive licensing agreement

25 May 2022

Our new Global Head of Drug Development and Chief Medical Officer

3 May 2022

Meet us digitally at the Bio-Europe Spring conference

28-31 March 2022

Featured in Nature Biopharma Dealmakers

1 March 2022

Ellipses Announces Growth in Oncology Portfolio

16 September 2021

Kelun and Ellipses Announce a Licensing Agreement for A400

26 March 2021

Resistance-Busting ICR Drug Enters Clinical Trial

19 March 2021

Professor Gordon McVie

22 January 2021

Radius Health Divests RAD 140 Program to Ellipses Pharma

1 October 2020

Ellipses Brand Assets

Ellipses Brochure

Ellipses Business Development Brochure

Ellipses Scientific Affairs Group Brochure

Ellipses Scientific Affairs Group Animation

Professor Sir Christopher Evans OBE

Dr Rajan Jethwa

For all media enquiries, please get in touch

Contact us